Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.

Autor: Pilsworth JA; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Cochrane DR; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Xia Z; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Aubert G; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada., Färkkilä AEM; Children's Hospital and Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA., Horlings HM; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Yanagida S; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan., Yang W; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Lim JLP; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Wang YK; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Bashashati A; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Keul J; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Wong A; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Norris K; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK., Brucker SY; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Taran FA; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Krämer B; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Staebler A; Tübingen University Hospital, Institute of Pathology, Tübingen, Germany., van Meurs H; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, Academic Medical Center, 1100 DD, Amsterdam, The Netherlands., Oliva E; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Shah SP; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Computer Science, University of British Columbia, Vancouver, BC, Canada., Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Kommoss F; Institute of Pathology, Campus Bodensee, Friedrichshafen, Germany., Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Baird DM; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK., Huntsman DG; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. dhuntsma@bccancer.bc.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. dhuntsma@bccancer.bc.ca.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2019 Apr; Vol. 32 (4), pp. 593.